OrsoBio
PrivateLast Round
Series B
Sep 6, 2024
Total Funding Raised
$166.3M
Company Overview
OrsoBio operates in Healthcare & Life Sciences and is based in Menlo Park, California. Its latest recorded funding round was a Series B round in September 2024.
OrsoBio is a biopharmaceutical company that develops first-in-class therapies to treat severe metabolic disorders, including obesity, type 2 diabetes, MASH, and severe dyslipidemia.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OrsoBio Comparables
Compare OrsoBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rivus Pharmaceuticals | 86% | |
| Eolo Pharma | 79% | |
| AdipoPharma | 78% |
For institutional investors. Book with your work email.
OrsoBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 6, 2024 | ||||
| Series A | Nov 7, 2023 | ||||
| Grant | Nov 2, 2022 | ||||
| Seed | Nov 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
OrsoBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longitude Capital | Series B, Series A |
| Enavate Sciences | Series B, Series A |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| Samsara BioCapital | Series A, Series B, Seed |
| Woodline Partners | Series B |
| NuevaBio | Series A, Seed, Series B |
| Ascenta Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
Monthly visitors increased 79% MoM, reaching 3.8K.
- Sep 6, 2024
$67M round led by Ascenta Capital.
For institutional investors. Book with your work email.
OrsoBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about OrsoBio's valuation, stock price, and market status.
Is OrsoBio a public or private company?
OrsoBio is a private company.
What is the current stock price of OrsoBio?
OrsoBio is a private company, so its shares have no public market price. Caplight tracks OrsoBio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is OrsoBio worth (valuation)?
Valuation information for OrsoBio is not publicly available.
Can I buy OrsoBio stock?
OrsoBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was OrsoBio's last funding round?
OrsoBio's most recent funding round was Series B on September 6, 2024.
Who are the main investors in OrsoBio?
Key investors in OrsoBio include Longitude Capital, Enavate Sciences, Samsara BioCapital, Ascenta Capital.
Will OrsoBio IPO soon?
No public IPO plans have been announced for OrsoBio.
How can I track OrsoBio secondary market activity?
Caplight tracks bids, offers, and trades in OrsoBio's shares on secondary markets.